Table 2.
GH and IGF-I concentrations at different time points
| GH (mU/l) | IGF-I (nmol/l) | |||||
|---|---|---|---|---|---|---|
| aSAH | Control | P value | aSAH | Control | P value | |
| day1 | 3.4 ± 5.5 | 1.6 ± 2.7 | 0.18 | 8.2 ± 3.1 | 10.5 ± 2.7 | 0.04 |
| day2 | 3.5 ± 5.5 | 4.5 ± 5.3 | 0.48 | 8.4 ± 3.6 | 11.9 ± 3.1 | <0.01 |
| day3 | 3.0 ± 5.3 | 1.8 ± 1.6 | 0.37 | 8.1 ± 4.2 | 11.4 ± 4.2 | <0.01 |
| day4 | 2.4 ± 4 | 3.5 ± 4.5 | 0.54 | 7.8 ± 3.9 | 10.9 ± 3.8 | 0.01 |
| day5 | 2.0 ± 2.1 | 2.4 ± 3.7 | 0.72 | 8.0 ± 4.4 | 11.1 ± 4.1 | <0.01 |
| day6 | 2.1 ± 2.4 | 7.8 ± 4.0 | ||||
| day7 | 1.6 ± 2.4 | 7.7 ± 4.0 | ||||
| 3 months | 2.0 ± 5.1 | 3.7 ± 5.0 | 0.23 | 9.7 ± 3.1 | 10.4 ± 2.4 | 0.9 |
Data are presented as mean values ± standard deviations.
aSAH, aneurysmal subarachnoid hemorrhage;GH, growth hormone; IGF-I: Insulin like growth factor-I.